In Siriraj Hospital, Colistin alone for treatment of MDR. A.baumanii or P.aeruginosa contributed to mortality 45%. In vitro studies revealed synergism of Rifampicin and Colistin. In this study, patients with documented MDR. P.aeruginosa or A.baumanii will be allocated to receive Colistin alone and another group will receive Colistin plus Rifampicin.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
130
Colistimethate Sodium dose 2.5-5mg/kg/day
Colistin 2.5 to 5 mg/ Kg/ day Rifampin 10 mg/ Kg/ day
Division of Infectious disease and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital
Bangkoknoi, Bangkok, Thailand
RECRUITINGnumber of subjects with cure or improvement
Cure Improvement Worse Death
Time frame: up to day 28
number of subjects with eradication of causative bacteria
Eradication Persistence Superinfection
Time frame: up to day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.